News – Page 1103 – Endpoints News

Under fire from Shire, Roche grabs the VIP lane for top drug prospect emicizumab

8 years ago

Meet Bertrand Bodson, Novartis’ new global digital strategy maestro for all things Big Pharma

8 years ago

AstraZeneca researchers plumb positive data to back extended use of Brilinta

8 years ago

EMA and FDA will now share trade secrets, allowing both regulators to act on each other's inspection reports

8 years ago

Key figure in notorious biopharma insider case loses an appeal — broadening scope for future cases

8 years ago

Can Amgen beat down payer resistance to Repatha with its own cost analysis?

8 years ago

Here’s why 23-year-old Laura Deming is betting $22M on anti-aging R&D

8 years ago

Amgen backs a fresh raise for AI player GNS Healthcare; SQZ names Agarwal as new CMO

8 years ago

Eli Lilly partners at CRUK tackle the first human study of a new p53-targeted cancer drug

8 years ago

Paratek shares soar as the antibiotic developer posts a ‘for sale’ sign

8 years ago

PhIII bust forces Ultragenyx to scrap drug for rare muscle disease

8 years ago

Indivior opens up a $30M R&D center; Lilly strikes discovery deal with Topas

8 years ago

New docs spotlight the FDA’s failed attempt to get Sarepta’s flawed Duchenne study retracted

8 years ago

FDA throws up another roadblock to Cardiome, 9 years after rejecting its drug

8 years ago

The best — and worst — biotech IPOs in the class of 2017

8 years ago

Big names, big companies back a cell therapy startup run by a high-profile regenerative med expert

8 years ago

Building up its I/O ops, CRISPR Therapeutics allies with Marcela Maus at Mass General

8 years ago

Jurors: In the end, Martin Shkreli was done in by his own inflated ego

8 years ago

Personal turf is ‘out,’ community workplaces are ‘in’ at the new Roche neighborhood

8 years ago

Shire CFO to jump ship; Akari taps Zealand vet as new CEO

8 years ago

After two years of negotiations, FDA gets its user fee programs authorized through 2022

8 years ago

Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo

8 years ago

Struggling AstraZeneca ups the ante on mRNA pipeline work

8 years ago

Top 10 pipeline blowups, setbacks and snafus in H1 2017

8 years ago

First page Previous page 1100 1101 110211031104 1105 1106 Next page Last page